SHANNON JAMES SAMUEL purchased 70K shares of XILIO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $48.1K. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 6/18/2025ACC: 0001415889-25-017705
Director
Since Jun 2024
+70K
Net shares
Net buyer
$48.1K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
70K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+45K
Price / share
$0.69
Trade value
$30.87K
% of position
New position
6/16/2025
0.00→45K
Common Stock
Direct
Shares
+25K
Price / share
$0.69
Trade value
$17.21K
% of position
55.6%
6/17/2025
45K→70K
Total
Net shares
+70K
Net value
$48.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/16/2025 | P · Purchase | +45K | $0.69 | $30.87K | New position | 0.00 | 45K |
| Common Stock Direct | 6/17/2025 | P · Purchase | +25K | $0.69 | $17.21K | 55.6% | 45K | 70K |
| Total | +70K | $48.09K | ||||||
Derivative Transactions0
No derivative transactions reported